SCHEMBL26075337

SCHEMBL26075337

COc1ccc(-c2ccc(-c3cc(C=O)c4cc(C)ccc4n3)cc2F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.49
▸ DHODH Q02127 1/20 0.45
▸ ACACA Q13085 1/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ GAA P10253 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ GRM2 Q14416 1/20 0.43
▸ AURKA O14965 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ PLA2G2A P14555 2/20 0.43
▸ ERN1 O75460 1/20 0.42
▸ APP P05067 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ TP53 P04637 2/20 0.41
▸ ACP1 P24666 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075408 0.89 DHODH (0.45) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075381 0.89 MAPT (0.38) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075369 0.89 KDM4E (0.40) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075401 0.86 DHODH (0.44) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075378 0.86 XDH (0.39) MAPTDHODHACACAKDM4EALDH1A1
SCHEMBL26075357 0.85 PLA2G2A (0.42) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075421 0.85 ALDH1A1 (0.40) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075426 0.85 ALDH1A1 (0.45) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075374 0.84 TP53 (0.36) MAPTDHODHKDM4EALDH1A1HPGD
SCHEMBL26075413 0.84 KDM4E (0.42) MAPTDHODHKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD MAPT 2689/4885DHODH 1/4885ACACA 1205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback